Mendelian Randomization analysis of the causal effect of adiposity on hospital costs.


Journal

Journal of health economics
ISSN: 1879-1646
Titre abrégé: J Health Econ
Pays: Netherlands
ID NLM: 8410622

Informations de publication

Date de publication:
03 2020
Historique:
received: 25 04 2019
revised: 06 01 2020
accepted: 14 01 2020
pubmed: 6 2 2020
medline: 28 7 2021
entrez: 5 2 2020
Statut: ppublish

Résumé

Estimates of the marginal effect of measures of adiposity such as body mass index (BMI) on healthcare costs are important for the formulation and evaluation of policies targeting adverse weight profiles. Most estimates of this association are affected by endogeneity bias. We use a novel identification strategy exploiting Mendelian Randomization - random germline genetic variation modelled using instrumental variables - to identify the causal effect of BMI on inpatient hospital costs. Using data on over 300,000 individuals, the effect size per person per marginal unit of BMI per year varied according to specification, including £21.22 (95% confidence interval (CI): £14.35-£28.07) for conventional inverse variance weighted models to £18.85 (95% CI: £9.05-£28.65) for penalized weighted median models. Effect sizes from Mendelian Randomization models were larger in most cases than non-instrumental variable multivariable adjusted estimates (£13.47, 95% CI: £12.51-£14.43). There was little evidence of non-linearity. Within-family estimates, intended to address dynastic biases, were imprecise.

Identifiants

pubmed: 32014825
pii: S0167-6296(19)30408-4
doi: 10.1016/j.jhealeco.2020.102300
pmc: PMC7188219
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

102300

Subventions

Organisme : Medical Research Council
ID : MR/P014259/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12013/9
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12013/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflicts of interest.

Références

BMJ. 2018 Jul 12;362:k601
pubmed: 30002074
Int J Epidemiol. 2019 Jun 1;48(3):702-712
pubmed: 30462199
Nat Commun. 2016 Feb 01;7:10495
pubmed: 26833246
Obes Rev. 2011 Feb;12(2):131-41
pubmed: 20122135
Health Serv Res. 2018 Jun;53(3):1621-1643
pubmed: 28516496
Perspect Psychol Sci. 2010 Sep;5(5):527-45
pubmed: 26162196
Am J Hum Genet. 2012 Jan 13;90(1):7-24
pubmed: 22243964
J Health Econ. 2011 Jul;30(4):647-59
pubmed: 21664708
Diabetes. 2016 Oct;65(10):3002-7
pubmed: 27402723
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Int J Epidemiol. 2019 Jun 1;48(3):691-701
pubmed: 30325422
Elife. 2019 Mar 21;8:
pubmed: 30895923
Hum Mol Genet. 2019 Apr 15;28(8):1322-1330
pubmed: 30561638
JAMA. 2017 Feb 14;317(6):626-634
pubmed: 28196256
Am J Epidemiol. 2018 Dec 1;187(12):2681-2685
pubmed: 30188969
Lancet. 2016 Apr 2;387(10026):1349-1350
pubmed: 27115799
Lancet. 2011 Feb 12;377(9765):557-67
pubmed: 21295846
Eur J Epidemiol. 2017 May;32(5):377-389
pubmed: 28527048
Science. 2018 Jan 26;359(6374):424-428
pubmed: 29371463
JAMA Cardiol. 2017 Aug 1;2(8):882-889
pubmed: 28678979
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8026-31
pubmed: 22566634
Hum Mol Genet. 2018 Oct 15;27(20):3641-3649
pubmed: 30124842
Annu Rev Genomics Hum Genet. 2015;16:327-50
pubmed: 25939054
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
J Health Econ. 2016 Jan;45:131-48
pubmed: 26614692
Pharmacoeconomics. 2015 Jul;33(7):707-22
pubmed: 25381647
Health Econ. 2011 Aug;20(8):884-8
pubmed: 21612000
Int J Epidemiol. 2017 Dec 1;46(6):1985-1998
pubmed: 29040600
Lancet. 2005 Nov 5;366(9497):1589-91
pubmed: 16271629
BMJ. 2018 May 16;361:k1767
pubmed: 29769355
Psychol Sci. 2014 Nov;25(11):1975-86
pubmed: 25287667
Elife. 2018 May 30;7:
pubmed: 29846171
J Health Econ. 2008 Mar;27(2):519-29
pubmed: 18166236
Nat Commun. 2019 Jan 18;10(1):333
pubmed: 30659178
Lancet. 2013 Aug 3;382(9890):427-451
pubmed: 23746772
J Health Econ. 2009 May;28(3):578-97
pubmed: 19217678
Biometrika. 1950 Dec;37(3-4):256-66
pubmed: 14801052
Int J Epidemiol. 2019 Jun 1;48(3):713-727
pubmed: 30535378
Trends Genet. 2013 Feb;29(2):66-73
pubmed: 23140989
Obesity (Silver Spring). 2016 Aug;24(8):1630-8
pubmed: 27460712
Stat Methods Med Res. 2017 Oct;26(5):2333-2355
pubmed: 26282889
Nat Rev Genet. 2018 Sep;19(9):566-580
pubmed: 29872216
Nat Commun. 2020 Feb 21;11(1):1010
pubmed: 32081875
Wellcome Open Res. 2017 Feb 14;2:11
pubmed: 28405635
Health Econ. 2008 Sep;17(9):1089-104
pubmed: 18615836
Lancet. 2011 Aug 27;378(9793):815-25
pubmed: 21872750
Appl Health Econ Health Policy. 2019 Jun;17(3):359-370
pubmed: 30599049
Nat Genet. 2016 Jul;48(7):709-17
pubmed: 27182965
Am J Epidemiol. 2015 Feb 15;181(4):251-60
pubmed: 25632051
PLoS Med. 2008 Mar 4;5(3):e52
pubmed: 18318597
J R Soc Med. 2007 Sep;100(9):432-5
pubmed: 17766918
Curr Dir Psychol Sci. 2015 Jul 1;24(4):304-312
pubmed: 26556960
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Nat Commun. 2020 Jul 14;11(1):3519
pubmed: 32665587
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
BMJ. 2012 Nov 06;345:e7325
pubmed: 23131671
J Health Econ. 2015 Sep;43:244-68
pubmed: 26279519
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Epidemiology. 2019 May;30(3):350-357
pubmed: 30896457
Lancet. 2003 Feb 15;361(9357):598-604
pubmed: 12598158
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):354-9
pubmed: 25548176
JAMA. 2016 Jul 5;316(1):63-9
pubmed: 27380344
Hum Mol Genet. 2014 Sep 15;23(R1):R89-98
pubmed: 25064373
J Health Econ. 2012 Jan;31(1):219-30
pubmed: 22094013
Epidemiology. 2011 Jul;22(4):450-6
pubmed: 21490505
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
Pharmacoeconomics. 2016 Nov;34(11):1075-1086
pubmed: 27484822
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Nat Rev Cardiol. 2017 Nov;14(11):635-636
pubmed: 28980665
Health Econ. 2011 Aug;20(8):889-92
pubmed: 21612001
Health Econ. 2011 Aug;20(8):893-6
pubmed: 21612002
Annu Rev Nutr. 2019 Aug 21;39:317-338
pubmed: 31116649
Nat Rev Genet. 2005 Feb;6(2):95-108
pubmed: 15716906
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
PLoS Comput Biol. 2012;8(12):e1002822
pubmed: 23300413
Obesity (Silver Spring). 2018 Nov;26(11):1796-1806
pubmed: 30358150
Lancet. 2005 Nov 5;366(9497):1640-9
pubmed: 16271645
Genet Epidemiol. 2017 May;41(4):341-352
pubmed: 28317167
Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):105-15
pubmed: 23731873
BMJ. 2009 Dec 22;339:b5043
pubmed: 20028778
PLoS Med. 2007 Dec;4(12):e352
pubmed: 18076282
Econ Hum Biol. 2017 Nov;27(Pt A):84-92
pubmed: 28550809
Stat Biosci. 2011 Sep;3(1):6-27
pubmed: 22010051
Annu Rev Econom. 2012 Jul 1;4:627-662
pubmed: 23482589
PLoS One. 2014 Oct 10;9(10):e108891
pubmed: 25302496
Nat Rev Genet. 2008 May;9(5):356-69
pubmed: 18398418
Hum Genet. 2008 Feb;123(1):15-33
pubmed: 18038153
Lancet. 2003 Mar 8;361(9360):865-72
pubmed: 12642066
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Econ Hum Biol. 2018 Sep;31:1-13
pubmed: 30064082
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
Behav Genet. 1972 Jun-Sep;2(2):127-57
pubmed: 4664207
Econ Hum Biol. 2015 Dec;19:27-44
pubmed: 26256130
Health Technol Assess. 2004 May;8(21):iii-iv, 1-182
pubmed: 15147610
Genetics. 2010 Nov;186(3):767-73
pubmed: 21062962
Nat Rev Cancer. 2002 Nov;2(11):862-71
pubmed: 12415256
J Am Stat Assoc. 2019 Apr 30;114(528):1436-1449
pubmed: 32165869
Econ J (London). 2014 May;124(576):634-667
pubmed: 25431500
Pharmacoeconomics. 2006;24(11):1055-68
pubmed: 17067191
Sci Rep. 2015 Dec 21;5:18422
pubmed: 26687910
Genet Epidemiol. 2018 Oct;42(7):608-620
pubmed: 29971821
Eur Econ Rev. 2013 Jan;57:1-22
pubmed: 25673883
Lancet. 2012 Mar 31;379(9822):1173-4
pubmed: 22463865
Int J Epidemiol. 2019 Jun 1;48(3):665-671
pubmed: 31263889
Nat Rev Cardiol. 2017 Oct;14(10):577-590
pubmed: 28569269
Stat Med. 2015 Feb 10;34(3):454-68
pubmed: 25382280
Hum Mol Genet. 2018 Aug 1;27(R2):R195-R208
pubmed: 29771313
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Int J Epidemiol. 2010 Apr;39(2):329-35
pubmed: 20176585
Am J Clin Nutr. 2016 Apr;103(4):965-78
pubmed: 26961927

Auteurs

Padraig Dixon (P)

Population Health Sciences, University of Bristol, United Kingdom; MRC Integrative Epidemiology Unit, University of Bristol, United Kingdom. Electronic address: padraig.dixon@bristol.ac.uk.

William Hollingworth (W)

Population Health Sciences, University of Bristol, United Kingdom.

Sean Harrison (S)

Population Health Sciences, University of Bristol, United Kingdom; MRC Integrative Epidemiology Unit, University of Bristol, United Kingdom.

Neil M Davies (NM)

Population Health Sciences, University of Bristol, United Kingdom; MRC Integrative Epidemiology Unit, University of Bristol, United Kingdom.

George Davey Smith (G)

Population Health Sciences, University of Bristol, United Kingdom; MRC Integrative Epidemiology Unit, University of Bristol, United Kingdom; NIHR Biomedical Research Centre, University of Bristol, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH